associated with the amount of LV fibrosis, 4 symptoms' onset, and long-term outcomes. 5 The assessment of myocardial work by pressure-strain loops (PSLs) is a recently introduced tool that allows to estimate the myocardial performance. Recent studies have shown that the amount of myocardial constructive work is a predictor of cardiac resynchronization therapy response. 6, 7 The amount of myocardial work assessed by PSLs is also correlated with the uptake of fluro-deoxyglucose at myocardial positron emission tomography (PET) scan, 8 which implies a relationship between the non-invasive estimation of myocardial work and myocardial metabolism. No previous study has assessed myocardial work in patients with HCM. Thus, the aims of this survey were (a) to compare myocardial work in patients with non-obstructive HCM vs normal subjects; (b) to evaluate if myocardial work indices could be relevant parameters for the assessment of LV fibrosis.
| MATERIAL AND ME THODS

| Population
Eighty-two patients with non-obstructive HCM were consecutively recruited from our Regional Competence Center of Genetic
Disease. The diagnosis of HCM was established according to current guidelines. 1 Patients with obstructive cardiomyopathy, concomitant moderate or severe valvular heart disease, myocardial storage disease, uncontrolled hypertension, and coronary artery disease were excluded from the study. All HCM patients underwent clinical examination, standard and speckle-tracking 2D-transthoracic echocardiography, 48-hour Holter monitoring, and cardiopulmonary exercise test (CPET). A subset of patients was investigated with cardiac magnetic resonance (CMR). All patients were screened for mutation in myosin-binding protein C (MYBPC3), β-myosin heavy chain (MYH7), regulatory and essential light chain of myosin (MYL2 and MYL3), and cardiac troponin
T (TNN2) and I (TNNI3).
Twenty age-matched healthy individuals were also included in the study as a control group. Controls were recruited from healthy hospital staff, and people screened for working license. The study was conducted in accordance with the "Good Clinical Practice"
Guidelines as laid down in the Declaration of Helsinki and reviewed by an independent ethics committee. All patients gave their written informed consent to participate in the study.
| Echocardiography
All patients underwent standard transthoracic echocardiography using a Vivid 7, Vivid E9, or E95 ultrasound system (GE Healthcare, Horten, Norway) equipped with a 3S or M5S 3.5-mHz transducer.
2D, color Doppler, pulsed-wave, and continuous-wave Doppler data were stored on a dedicated workstation for the offline analysis (EchoPAC, GE Healthcare). LV volumes and function were measured by the biplane method as recommended. 9 LA volume, LA anteroposterior diameter, and LV diastolic function were assessed as recommended. 9, 10 To calculate LV global longitudinal strain (GLS), two-dimensional grayscale images were acquired in the apical 4-, 3-, and 2-chamber views at a frame rate ≥60 frames/s. The recordings were processed using an acoustic-tracking dedicated software (EchoPAC version 112.99, Research Release, GE Healthcare), to estimate LV global longitudinal strain (GLS). 11 Mechanical dispersion was calculated as the standard deviation of the time to maximal myocardial shortening, measured from the electrocardiographic onset Q/onset R-wave in the 17 LV segments.
12,13
| Myocardial work quantification
Myocardial work and related indices were estimated using custom software. Myocardial work was estimated as a function of time throughout the cardiac cycle by the combination of LV strain data obtained by speckle-tracking echocardiography and a noninvasively estimated LV pressure curve, as described in previous works. 6, 7, 14 A 17-segment model was used for the estimation of segmental myocardial work. LV global longitudinal strain (GLS) was calculated as recommended. 11 Peak arterial pressure measured with a cuff-manometer was assumed to be equal to peak systolic LV pressure and to be uniform throughout the ventricle. The resulting non-invasive LV pressure curve was obtained using an empiric, normalized reference curve that was adjusted according to the duration of the isovolumetric and ejection phases of the LV, defined by the timing of aortic and mitral valve events by echocardiography ( Figure 1A ). The reliability of this non-invasively estimated LV pressure curve was previously validated in a dog model and in patients with dilated cardiomyopathy and LV dyssynchrony. 8, 14 Strain and pressure data were synchronized using the R-wave on ECG as a common time reference. Myocardial work was then quantified by calculating the rate of segmental shortening by differentiating the strain curve and multiplying the resulting value by the instantaneous LV pressure ( Figure 1B) . The result is a measure of instantaneous power, which was integrated over time to obtain myocardial work as a function of time.
Work was calculated from mitral valve closure until mitral valve opening. During the isovolumic contraction and LV ejection period, segmental shortening contributes to the final LV ejection, whereas segmental stretch or lengthening does not contribute to LV ejection.
As a result, the work performed by the myocardium during segmental shortening represents constructive work, whereas the work performed by the myocardium during stretch or segmental lengthening represents energy loss, which is defined as wasted work. During isovolumic relaxation, segmental lengthening contributes to LV relaxation, whereas segmental shortening does not. As a result, the work performed by the myocardium during segmental shortening, which does not promote LV relaxation, was considered wasted work, 
| Cardiopulmonary exercise test
All subjects underwent a progressive exercise test on an ergocycle (ERG 900; Jaeger, Hochberg, Germany) according to the recommendations. 15 The initial workload of 30 Watts was progressively increased by 15-25 W every 2 minutes until symptoms' onset or maximal exertion was reached. Breath-by-breath gas exchanges
were analyzed using an Oxycon device (Jaeger), and the electrocardiogram (CardioSys; Marquette-Hellige, Freiburg, Germany)
was continuously monitored to detect eventual arrhythmias and/ or repolarization alterations. The maximal oxygen uptake peak was (VO 2 peak ) expressed as a percentage of the predicted value.
| Cardiac magnetic resonance imaging
Cardiac magnetic resonance was performed on a 3-T clinical magnetic resonance system (Ingenia, Philips Medical Systems, Best, the Netherlands) with a 32-channel cardiovascular array coil.
LGE images were acquired 10-15 minutes after intravenous administration of 0.2 mmol/kg of gadolinium (Gadoterate meglumine, Dotarem, Guerbet, Aulnay-sous-bois, France), using 2D breath-hold inversionrecovery and phase-sensitive inversion-recovery sequences in shortaxis plane (spoiled gradient-echo, slice thickness 8 mm, repetition time 6.1 ms, echo time 2.9 ms, flip angle 25°, inversion time adjusted to null normal myocardium, typical breath-hold 11 seconds). The regional LGE extent was semiquantitatively assessed on a per-segment basis (AHA 17-segment model, leaving out the apex). The presence of ≥2 segments with LGE was chosen to define significant fibrosis. 
| Statistical analysis
| RE SULTS
| Main characteristics of patients and controls
We included in the study 82 patients and 20 healthy controls.
Compared to controls, patients had significant LV hypertrophy (P < 0.0001). No difference in LVEF was observed between patients and controls. HCM was associated with increased LA volume and diastolic dysfunction. GLS, mechanical dispersion, and GCW were significant impaired in HCM (all P < 0.0001; Figure 2A ).
GWW was slightly increased in HCM compared to controls, but this difference did not reach statistical significance (Table 1 ). All patients underwent genetic testing, and 22 (27%) had confirmed HCM-related pathogenic mutations. The presence of a sarcomere myofilament mutation was not associated with significant difference in GCW (ANOVA P = 0.66).
Following the Maron's classification, the most frequent hypertrophy patterns were type II (n = 55, 67%) and type III (n = 23, 28%).
Type I (n = 2, 2.4%) hypertrophy and type IV (n = 2, 2.4%) hypertrophy were rare. No differences in GCW were observed between these groups (ANOVA P = 0.43). Table 2 ). At ROC curve analysis, a cutoff of GCW of 1623 mm Hg% (AUC 0.80, 95%
| Cardiac magnetic resonance imaging findings
CI: 0.66-0.93, P < 0.0001) was able to predict myocardial fibrosis with good sensitivity and fair specificity (82% and 67%, respectively (Figure 4 ).
| Parameters related with myocardial constructive work
The main correlates of GCW at linear regression analyses are depicted in Table 3 . GCW was significantly associated with LV mass,
F I G U R E 2 Box plots of global constructive work (GCW) in 82 patients with hypertrophic cardiomyopathy (HCM) and 20 healthy controls (A). Box plots comparing GCW in HCM patients with (LGE+) and without (LGE−) significant left ventricular fibrosis at late gadolinium enhancement cardiac resonance imaging (B)
TA B L E 
| D ISCUSS I ON
This pilot study is the first to explore new pressure-strain loops indices measured by transthoracic echocardiography in nonobstructive hypertrophic cardiomyopathy. Myocardial constructive work was significantly reduced in HCM compared to healthy controls and emerged as a significant predictor of myocardial fibrosis.
| Assessment of myocardial performance in hypertrophic cardiomyopathy
In patients with HCM, myocardial fiber disarray and interstitial fibrosis are responsible for the progressive alteration of LV deformation parameters, which precedes overt LV dysfunction. 5, 13 Another important feature of HCM is coronary microvascular dysfunction, which contributes to myocardial ischemia, LV remodeling, and adverse outcomes. 16, 17 Previous studies have shown that LV deformation is significantly impaired in patients with HCM despite the presence of a preserved LVEF, 12, 13 and that LV mechanical dispersion is associated with myocardial fibrosis and arrhythmic events.
13
In our study GCW, GLS and mechanical dispersion were significantly impaired in HCM patients compared to controls, despite the presence of a similar LVEF.
The presence of LV fibrosis was associated with a further reduction of these functional parameters in patients with HCM, and GCW emerged as the main predictor of LV fibrosis at multivariable regression analysis. Previous studies by Russel et al 14 and Delhaas et al 18 have
shown that the estimation of myocardial work by pressure-strain loops is not a mere measure of myocardial deformation, but it is an index of regional and global myocardial oxygen consumption and metabolism.
In patients with HCM, different degrees of microvascular dysfunction have been described, 16, 17 which are associated with the localization 19 and global amount of myocardial fibrosis assessed by CMR. 17 According to these observations, the alteration of GCW observed in HCM patients might reflect both fibers disarray and metabolic impairment, becoming a sensitive marker of LV fibrosis. As a matter of fact, in our population, a cutoff of 1623 mm Hg% for GCW was able to predict myocardial fibrosis with a good sensitivity (82%) and fair specificity (67%).
In patients with HCM, LV systolic and diastolic function parameters assessed by transthoracic echocardiography, LV mass, NYHA class, and functional parameters assessed by CPET were all associated with GCW at univariable linear regression analysis. GCW estimation allows the assessment of LV function during the systolic and isovolumic relaxation phase. This might be of particular interest in patients with HCM, who experience a simultaneous impairment of LV deformation and diastolic properties.
In HCM, the alterations in LV geometry and mechanics are strictly associated with the development of LA dilatation and Interestingly, in the present study, VO 2 peak was the main correlate of GCW at multivariable analysis. Previous studies have shown that peak exercise parameters obtained by CPET are altered in patients with HCM. [22] [23] [24] The reduction in VO 2 peak is ascribed to a limited increase in cardiac output during exertion, 22, 23 which is attributable to the increased LV wall thickness, LV fibrosis, and microvascular dysfunction observed in HCM patients.
22
Through its relationship to VO 2 peak , GCW might provide an indirect estimation of functional capacity in HCM patients.
Compared to CPET, which require resources, expertise and training, the estimation of myocardial work can be easily performed by echocardiography and can be also applied to patients who are not able to exercise.
| Clinical perspectives
In patients with HCM, LV systolic function assessed by LVEF does not reflect the entity of LV functional impairment. Myocardial constructive work by pressure strain loop is a simple and useful tool that is correlated with functional capacity and is a predictor of LV fibrosis.
| Limitations
This is a retrospective study realized on a limited cohort of patients with non-obstructive HCM. The study population was heterogeneous in functional level, symptoms, and disease stage. CMR was performed only in a subset of patients, and myocardial fibrosis was estimated qualitatively. Further studies might explore the relationship between GCW and LV fibrosis as assessed quantitatively by
LGE 25 or T1 mapping. 26 Because of the limited number of patient included, the relationship between myocardial work and prognosis was not assessed in our survey. Follow-up studies to evaluate the relationship between GCW and events in HCM should be specifically designed.
| CON CLUS ION
Global constructive work assessed non-invasively by pressure-strain loops was significantly reduced in HCM despite the presence of a normal LVEF. GCW emerged as a predictor of LV fibrosis and was also correlated with VO 2 peak measured by CPET. These data support the utility of the estimation of GCW in HCM in order to estimate LV performance and overall functional capacity.
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